Constipation occurs in roughly 10% to 15% of users
Due to controlled batch production, verification requirements, and research demand, availability may vary over time
Berberine an herbal supplement used for cardiovascular and gut health in addition to weight management
It has passed phase 1 and 2 clinical trials and is currently in phase 3 trials, with an expected launch in 2026 or 2027 if approved
Interaction with GLP-1 receptor-expressing neurons here produces further activation of important brain nuclei, including the paraventricular and the arcuate nucleus, the nucleus of the solitary tract and the nucleus ambiguous, the bed nucleus of stria terminalis, the central nucleus of the amygdala and the parabrachial nucleus [10]
Still, it raises concerns about side effects, especially facial volume loss (Ozempic Face), which is now becoming a common topic in aesthetic medicine